Magda M F Ismail

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Squamous Cell Carcinoma

Silver Nanoparticles

Top Venues

Scientific reports

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammed Salah Ayoup, Islam Shawki, Hamida Abdel-Hamid, Doaa A Ghareeb, Aliaa Masoud, Marwa F Harras, Mohamed A El-Atawy, Nuha Salamah Alharbi, Magda M F Ismail
Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles. RSC advances 14 (24) (2024)
Mohammed Salah Ayoup, Islam Shawki, Hamida Abdel-Hamid, Doaa A Ghareeb, Aliaa Masoud, Marwa F Harras, Mohamed A El-Atawy, Nuha Salamah Alharbi, Magda M F Ismail
Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles. RSC advances 14 (24) (2024)
Mervat M Omran, Mona M Kamal, Yousry A Ammar, Moustafa S Abusaif, Magda M F Ismail, Heba H Mansour
Pharmacological investigation of new niclosamide-based isatin hybrids as antiproliferative, antioxidant, and apoptosis inducers. Scientific reports 14 (1) (2024)
Mohammed Salah Ayoup, Islam Shawki, Hamida Abdel-Hamid, Doaa A Ghareeb, Aliaa Masoud, Marwa F Harras, Mohamed A El-Atawy, Nuha Salamah Alharbi, Magda M F Ismail
Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles. RSC advances 14 (24) (2024)
Mervat M Omran, Mona M Kamal, Yousry A Ammar, Moustafa S Abusaif, Magda M F Ismail, Heba H Mansour
Pharmacological investigation of new niclosamide-based isatin hybrids as antiproliferative, antioxidant, and apoptosis inducers. Scientific reports 14 (1) (2024)
Magda M F Ismail, Taghreed Z Shawer, Rabab S Ibrahim, Mostafa S Abusaif, Mona M Kamal, Rasha M Allam, Yousry A Ammar
Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers. RSC advances 13 (45) (2023)
Mona H Ibrahim, Nagwan G El Menofy, Shereen M El Kiki, Farag F Sherbiny, Magda M F Ismail
Development of fluorinated nicotinonitriles and fused candidates as antimicrobial, antibiofilm, and enzyme inhibitors. Archiv der Pharmazie 355 (7) (2022)